A Maltese-based company that has developed a neurological tool to measure mental function and early dementia detection is looking for a commercial agency or distribution services agreement.

This Maltese-based company's team of experts consisting of neuroscientists, cognitive scientists, programmers, social scientists, and translators have developed a novel approach to detecting mental decline which can serve as a rapid tool for early dementia diagnosis. This is conducted through the use of their tool, an objective measure of cognitive abilities based on fully automatic neuro-scientific brain-wave analysis. The early dementia detection model put forward by this SME can help those suffering from dementia reclaim several healthy life years.They are expected to attain the CE class I medical device certification in March-April 2021, and the class 2A medical device certification in Q2 2023. They are interested in collaborations with partners in the medical field, particularly with hospitals, retirement homes, and nursing homes that are looking for a kind of tool offered by this company. A commercial agency agreement or distribution agency agreement is sought.